Category: News

The Keck School of Medicine of USC has received $2 million from the California Institute of Regenerative Medicine (CIRM) to further augment its newly launched cGMP Laboratory, a state-of-the-art facility designed to advance early-stage research into clinically viable cell and gene therapies. To expedite the translation of these therapies from the lab to the clinic,…Continue Reading $2 million grant boosts technological advancements in cutting-edge cell therapy manufacturing facility

A new laboratory designed to advance early-stage research into lifesaving, commercially viable therapies was celebrated on the USC Health Sciences Campus Tuesday night. Housed at the USC Norris Comprehensive Cancer Center, the USC/CHLA cGMP Laboratory will manufacture cell and gene therapies under the Food and Drug Administration’s good manufacturing practice (cGMP) standards. Therapies developed in…Continue Reading New USC/CHLA cGMP Lab opens to accelerate next-generation cell therapy

The essence of translational medicine is taking an idea from the drawing board and “translating” it into a real-world treatment that helps patients. The winding road of that process takes plenty of time, money and expertise, so it makes sense to place it all under one roof. USC and Children’s Hospital Los Angeles (CHLA) are…Continue Reading CHLA, Keck School, Keck Medicine and USC Norris partner on cell therapy program as construction on new facility begins

Mohamed Abou-el-Enein, MD, PhD, MSPH, has joined the Keck School of Medicine as the inaugural Executive Director of the Joint USC/CHLA Cell Therapy Program. He began his post Jan. 4. Abou-el-Enein will also serve as Medical Director of the new cGMP facility for cell and gene therapy that is under construction in the Norris Research…Continue Reading Mohamed Abou-el-Enein named Executive Director of USC/CHLA Cell Therapy Program